Table 5 Body mass and Body Mass Index (BMI) absolute values and changes in each treatment group
From: Effect of experimental hookworm infection on insulin resistance in people at risk of type 2 diabetes
baseline | 6 months | Δ6 mo. | 12 months | Δ12 mo. | 18 months | Δ18 mo. | 24 months | Δ24 mo. | |
|---|---|---|---|---|---|---|---|---|---|
Body mass (kg), Median and IQR (n) | |||||||||
Placebo | 105 | 107 | +2 | 99 | 0 | 105 | −1 | 106 | +2 |
89–115 (n = 12) | 91–115 (n = 12) | −4 to 4 | 90–113 (n = 8) | −4 to 4 | 89–119 (n = 8) | −8 to 9 | 91–118 (n = 6) | −4 to 5 | |
L3-20 | 103 | 101 | −3 | 104 | −1 | 93a | −5 | 93a | −5 |
86–131 (n = 13) | 82–134 (n = 12) | −3 to 1 | 90–133 (n = 11) | −5 to 1 | 76–120 (n = 8) | −12 to −3 | 77–124 (n = 7) | −10 to −1 | |
L3-40 | 102 | 102 | −1 | 106 | +1 | 109 | +2 | 108 | +4 |
90–131 (n = 11) | 86–130 (n = 11) | −2 to 1 | 91–129 (n = 10) | −2 to 6 | 100–136 (n = 8) | −1 to 8 | 94–133 (n = 9) | −2 to 6 | |
BMI (kg/m2), Median and IQR (n) | |||||||||
Placebo | 37 | 37 | +0.7 | 36 | +0.1 | 39 | −0.3 | 38 | +0.8 |
33–40 (n = 12) | 33–41 (n = 12) | −1.2 to 1.2 | 31–41 (n = 8) | −1.5 to 1.5 | 32–41 (n = 8) | −3.0 to 3.2 | 32–40 (n = 6) | −1.9 to 1.7 | |
L3-20 | 37 | 37 | −0.5 | 39 | −0.2 | 35a | −2.2 | 33a | −2.4 |
33–46 (n = 13) | 32–49 (n = 12) | −1.3 to 1.5 | 34–44 (n = 11) | −1.3 to 0.1 | 31–41 (n = 8) | −4.2 to −1 | 30–41 (n = 7) | −2.7 to −0.5 | |
L3-40 | 36 | 36 | −0.1 | 35 | +0.3 | 39 | +0.6 | 38 | +0.9 |
33–40 (n = 11) | 31–40 (n = 11) | −0.7 to 0.5 | 33–39 (n = 10) | −0.8 to 2.3 | 34–40 (n = 8) | −0.2 to 2.3 | 33–41 (n = 9) | −0.7 to 2.1 | |
